 David Bentley
Concepts (435)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| RNA Polymerase II | 54 | 2022 | 282 | 10.790 |
Why?
| | Transcription, Genetic | 55 | 2023 | 1323 | 7.190 |
Why?
| | RNA Precursors | 16 | 2023 | 136 | 4.880 |
Why?
| | RNA, Messenger | 33 | 2021 | 2657 | 4.230 |
Why?
| | RNA Processing, Post-Transcriptional | 15 | 2021 | 84 | 3.900 |
Why?
| | RNA Splicing | 16 | 2023 | 243 | 2.880 |
Why?
| | Transcription Elongation, Genetic | 6 | 2018 | 20 | 2.620 |
Why?
| | Saccharomyces cerevisiae Proteins | 12 | 2017 | 348 | 2.550 |
Why?
| | Histones | 9 | 2018 | 552 | 2.060 |
Why?
| | Poly A | 9 | 2022 | 47 | 2.000 |
Why?
| | Transcription Termination, Genetic | 3 | 2019 | 11 | 1.930 |
Why?
| | Transcriptional Elongation Factors | 6 | 2022 | 33 | 1.890 |
Why?
| | Saccharomyces cerevisiae | 11 | 2022 | 495 | 1.860 |
Why?
| | Nuclear Proteins | 11 | 2019 | 597 | 1.760 |
Why?
| | Exoribonucleases | 4 | 2019 | 39 | 1.700 |
Why?
| | RNA-Binding Proteins | 10 | 2021 | 371 | 1.640 |
Why?
| | Alternative Splicing | 8 | 2021 | 193 | 1.560 |
Why?
| | Cyclin-Dependent Kinases | 8 | 2020 | 111 | 1.320 |
Why?
| | RNA 3' End Processing | 5 | 2018 | 11 | 1.210 |
Why?
| | Promoter Regions, Genetic | 14 | 2018 | 1158 | 1.190 |
Why?
| | mRNA Cleavage and Polyadenylation Factors | 6 | 2018 | 28 | 1.110 |
Why?
| | Chromatin | 8 | 2017 | 441 | 1.060 |
Why?
| | Transcriptional Activation | 5 | 2018 | 348 | 1.030 |
Why?
| | HEK293 Cells | 8 | 2021 | 625 | 1.020 |
Why?
| | RNA | 7 | 2021 | 833 | 1.020 |
Why?
| | Protein Processing, Post-Translational | 4 | 2019 | 408 | 1.020 |
Why?
| | Polyadenylation | 3 | 2022 | 38 | 0.940 |
Why?
| | RNA Caps | 7 | 2014 | 33 | 0.880 |
Why?
| | DNA-Binding Proteins | 9 | 2019 | 1346 | 0.820 |
Why?
| | Transcription Factor TFIIH | 6 | 2020 | 33 | 0.800 |
Why?
| | Transcription Initiation, Genetic | 2 | 2018 | 12 | 0.780 |
Why?
| | Phosphorylation | 13 | 2022 | 1633 | 0.720 |
Why?
| | Protein Phosphatase 1 | 1 | 2019 | 32 | 0.720 |
Why?
| | DNA, Fungal | 2 | 2017 | 69 | 0.690 |
Why?
| | Introns | 5 | 2023 | 234 | 0.690 |
Why?
| | Chromatin Assembly and Disassembly | 3 | 2017 | 93 | 0.690 |
Why?
| | Transcription Factors | 12 | 2012 | 1570 | 0.680 |
Why?
| | RNA Cleavage | 1 | 2018 | 7 | 0.680 |
Why?
| | Cell Line | 16 | 2021 | 2707 | 0.640 |
Why?
| | Models, Genetic | 7 | 2015 | 595 | 0.620 |
Why?
| | Nucleosomes | 2 | 2011 | 131 | 0.590 |
Why?
| | RNA, Catalytic | 2 | 2009 | 182 | 0.580 |
Why?
| | Cell Nucleus | 6 | 2022 | 580 | 0.570 |
Why?
| | Methyltransferases | 3 | 2004 | 61 | 0.570 |
Why?
| | Yeasts | 4 | 2011 | 52 | 0.570 |
Why?
| | Kinetics | 6 | 2019 | 1624 | 0.560 |
Why?
| | Mutation | 17 | 2018 | 3457 | 0.560 |
Why?
| | Recombinant Fusion Proteins | 4 | 2016 | 653 | 0.530 |
Why?
| | Transcription Factors, TFII | 5 | 2012 | 37 | 0.520 |
Why?
| | Exons | 11 | 2021 | 307 | 0.520 |
Why?
| | Protein Engineering | 1 | 2016 | 107 | 0.510 |
Why?
| | DNA Polymerase II | 3 | 2005 | 29 | 0.500 |
Why?
| | RNA, Fungal | 2 | 2011 | 66 | 0.500 |
Why?
| | Terminator Regions, Genetic | 5 | 2006 | 12 | 0.490 |
Why?
| | Binding Sites | 11 | 2019 | 1224 | 0.490 |
Why?
| | Exonucleases | 2 | 2022 | 8 | 0.480 |
Why?
| | HeLa Cells | 10 | 2015 | 583 | 0.470 |
Why?
| | Genes, myc | 5 | 2007 | 46 | 0.470 |
Why?
| | Polymerase Chain Reaction | 3 | 2016 | 1012 | 0.460 |
Why?
| | RNA Stability | 2 | 2012 | 97 | 0.460 |
Why?
| | Oocytes | 10 | 2005 | 190 | 0.450 |
Why?
| | Nucleotidyltransferases | 4 | 2004 | 25 | 0.450 |
Why?
| | Genes, Fungal | 2 | 2010 | 49 | 0.430 |
Why?
| | Protein Kinases | 3 | 2010 | 310 | 0.430 |
Why?
| | Phosphoprotein Phosphatases | 2 | 2009 | 67 | 0.400 |
Why?
| | Protein Structure, Tertiary | 9 | 2015 | 823 | 0.390 |
Why?
| | Fungal Proteins | 5 | 2011 | 130 | 0.390 |
Why?
| | Phosphoserine | 1 | 2010 | 34 | 0.380 |
Why?
| | Humans | 65 | 2022 | 118974 | 0.380 |
Why?
| | Histone-Lysine N-Methyltransferase | 3 | 2017 | 99 | 0.370 |
Why?
| | Gene Expression Regulation, Fungal | 3 | 2017 | 67 | 0.370 |
Why?
| | Neoplasm Proteins | 3 | 2007 | 401 | 0.370 |
Why?
| | Dichlororibofuranosylbenzimidazole | 6 | 2009 | 8 | 0.360 |
Why?
| | RNA Folding | 2 | 2021 | 32 | 0.340 |
Why?
| | Genes, Regulator | 3 | 2004 | 33 | 0.330 |
Why?
| | RNA Splice Sites | 3 | 2021 | 35 | 0.320 |
Why?
| | Animals | 34 | 2018 | 33381 | 0.320 |
Why?
| | Molecular Sequence Data | 14 | 2014 | 2871 | 0.300 |
Why?
| | Repressor Proteins | 3 | 2014 | 377 | 0.300 |
Why?
| | Protein Binding | 6 | 2019 | 1975 | 0.300 |
Why?
| | Spliceosomes | 2 | 2023 | 38 | 0.290 |
Why?
| | Macromolecular Substances | 5 | 2010 | 201 | 0.270 |
Why?
| | Peptide Elongation Factors | 2 | 2022 | 14 | 0.260 |
Why?
| | Lysine | 1 | 2007 | 248 | 0.260 |
Why?
| | RNA Cap-Binding Proteins | 1 | 2004 | 4 | 0.250 |
Why?
| | DNA-Directed RNA Polymerases | 2 | 1997 | 52 | 0.240 |
Why?
| | RNA Polymerase III | 2 | 2017 | 25 | 0.240 |
Why?
| | RNA Editing | 3 | 2009 | 22 | 0.230 |
Why?
| | Methylation | 3 | 2011 | 204 | 0.230 |
Why?
| | Ovarian Neoplasms | 4 | 2013 | 420 | 0.230 |
Why?
| | RNA, Antisense | 1 | 2022 | 19 | 0.220 |
Why?
| | Amino Acid Sequence | 9 | 2014 | 2071 | 0.220 |
Why?
| | Models, Biological | 5 | 2020 | 1715 | 0.220 |
Why?
| | Chromatin Immunoprecipitation | 3 | 2012 | 136 | 0.220 |
Why?
| | Nucleotides | 1 | 2022 | 112 | 0.210 |
Why?
| | Models, Theoretical | 1 | 2006 | 556 | 0.210 |
Why?
| | Gene Expression Regulation, Neoplastic | 3 | 2017 | 1167 | 0.200 |
Why?
| | Chromosomal Proteins, Non-Histone | 2 | 2003 | 103 | 0.200 |
Why?
| | Gene Products, tat | 2 | 1998 | 21 | 0.200 |
Why?
| | Mice | 13 | 2018 | 15520 | 0.200 |
Why?
| | Ultraviolet Rays | 2 | 2018 | 381 | 0.200 |
Why?
| | HCT116 Cells | 2 | 2018 | 68 | 0.190 |
Why?
| | Proto-Oncogenes | 3 | 1989 | 27 | 0.190 |
Why?
| | Jumonji Domain-Containing Histone Demethylases | 2 | 2014 | 59 | 0.190 |
Why?
| | Base Sequence | 12 | 2007 | 2159 | 0.190 |
Why?
| | Gene Expression Regulation | 7 | 2018 | 2445 | 0.180 |
Why?
| | Transfection | 7 | 2007 | 888 | 0.180 |
Why?
| | HIV-2 | 2 | 1997 | 15 | 0.180 |
Why?
| | Xenopus | 6 | 2003 | 104 | 0.180 |
Why?
| | Genome, Human | 3 | 2015 | 387 | 0.180 |
Why?
| | Adenosine Triphosphatases | 2 | 2012 | 158 | 0.180 |
Why?
| | Peptide Chain Elongation, Translational | 2 | 1998 | 18 | 0.170 |
Why?
| | 3' Flanking Region | 1 | 2018 | 6 | 0.170 |
Why?
| | Glyceraldehyde-3-Phosphate Dehydrogenases | 2 | 2009 | 14 | 0.170 |
Why?
| | Hydrolysis | 2 | 2011 | 176 | 0.170 |
Why?
| | Phenanthrenes | 1 | 2018 | 10 | 0.170 |
Why?
| | Metallothionein | 1 | 1998 | 24 | 0.170 |
Why?
| | Diterpenes | 1 | 2018 | 31 | 0.170 |
Why?
| | Coenzymes | 1 | 1998 | 20 | 0.170 |
Why?
| | Epoxy Compounds | 1 | 2018 | 33 | 0.170 |
Why?
| | Isotonic Solutions | 1 | 2018 | 43 | 0.160 |
Why?
| | Zebrafish Proteins | 1 | 2001 | 252 | 0.160 |
Why?
| | Saline Solution, Hypertonic | 1 | 2018 | 56 | 0.160 |
Why?
| | Genes | 5 | 2004 | 231 | 0.160 |
Why?
| | Trans-Activators | 2 | 2002 | 373 | 0.150 |
Why?
| | Progestins | 1 | 2017 | 77 | 0.150 |
Why?
| | Enzyme Inhibitors | 2 | 2003 | 827 | 0.150 |
Why?
| | Cell Cycle Proteins | 2 | 2003 | 565 | 0.140 |
Why?
| | Xenopus laevis | 4 | 2004 | 128 | 0.140 |
Why?
| | Tetrahydrofolate Dehydrogenase | 1 | 2016 | 14 | 0.140 |
Why?
| | Plasmids | 5 | 2006 | 355 | 0.140 |
Why?
| | Drosophila Proteins | 2 | 2003 | 171 | 0.140 |
Why?
| | Protein Domains | 1 | 2017 | 212 | 0.140 |
Why?
| | Neoplasms | 3 | 2021 | 2179 | 0.140 |
Why?
| | HIV-1 | 2 | 1998 | 776 | 0.130 |
Why?
| | Receptors, Progesterone | 1 | 2017 | 325 | 0.130 |
Why?
| | CRISPR-Cas Systems | 1 | 2016 | 85 | 0.130 |
Why?
| | Gene Expression Regulation, Enzymologic | 2 | 2007 | 290 | 0.130 |
Why?
| | Receptors, Estrogen | 1 | 2017 | 387 | 0.120 |
Why?
| | Proto-Oncogene Proteins | 3 | 1988 | 618 | 0.120 |
Why?
| | Immunoglobulin M | 1 | 2015 | 253 | 0.120 |
Why?
| | Escherichia coli Proteins | 1 | 2016 | 170 | 0.120 |
Why?
| | Lymphocytes | 1 | 2015 | 347 | 0.120 |
Why?
| | Histone Chaperones | 1 | 2013 | 14 | 0.120 |
Why?
| | Granulomatous Disease, Chronic | 2 | 1991 | 61 | 0.120 |
Why?
| | Signal Transduction | 4 | 2019 | 4709 | 0.120 |
Why?
| | Breast Neoplasms | 4 | 2017 | 1965 | 0.120 |
Why?
| | Cyclin-Dependent Kinase 9 | 2 | 2012 | 9 | 0.120 |
Why?
| | Neoplasms, Glandular and Epithelial | 1 | 2013 | 41 | 0.120 |
Why?
| | Cytidine Deaminase | 1 | 2013 | 57 | 0.110 |
Why?
| | Cystadenocarcinoma, Serous | 1 | 2013 | 49 | 0.110 |
Why?
| | Chloramphenicol O-Acetyltransferase | 3 | 1997 | 37 | 0.110 |
Why?
| | Antibodies | 4 | 2006 | 392 | 0.110 |
Why?
| | Cell Line, Tumor | 5 | 2014 | 2851 | 0.110 |
Why?
| | DNA, Neoplasm | 1 | 2013 | 154 | 0.110 |
Why?
| | Globins | 3 | 1997 | 22 | 0.110 |
Why?
| | Sequence Deletion | 2 | 2003 | 171 | 0.100 |
Why?
| | Carcinogenesis | 1 | 2013 | 182 | 0.100 |
Why?
| | Ovary | 1 | 2013 | 205 | 0.100 |
Why?
| | Proto-Oncogene Proteins c-myc | 3 | 2009 | 115 | 0.100 |
Why?
| | Escherichia coli | 1 | 2016 | 758 | 0.100 |
Why?
| | Ribonucleoproteins, Small Nuclear | 1 | 2011 | 23 | 0.100 |
Why?
| | beta-Globins | 1 | 2011 | 16 | 0.100 |
Why?
| | Protein Interaction Mapping | 1 | 2012 | 104 | 0.100 |
Why?
| | 3' Untranslated Regions | 2 | 2022 | 142 | 0.100 |
Why?
| | Serine | 2 | 2009 | 138 | 0.100 |
Why?
| | Repetitive Sequences, Amino Acid | 2 | 2001 | 16 | 0.100 |
Why?
| | Plasma | 1 | 2013 | 224 | 0.100 |
Why?
| | DNA Helicases | 3 | 1997 | 131 | 0.100 |
Why?
| | Isoquinolines | 2 | 2004 | 41 | 0.100 |
Why?
| | Recombinant Proteins | 4 | 1998 | 1308 | 0.100 |
Why?
| | NADH, NADPH Oxidoreductases | 1 | 1990 | 18 | 0.100 |
Why?
| | Time Factors | 4 | 2017 | 6412 | 0.090 |
Why?
| | Genes, Reporter | 2 | 2003 | 270 | 0.090 |
Why?
| | DNA | 5 | 2005 | 1388 | 0.090 |
Why?
| | Chromosome Deletion | 4 | 1992 | 95 | 0.090 |
Why?
| | RNA, Untranslated | 1 | 2011 | 115 | 0.090 |
Why?
| | Antimetabolites, Antineoplastic | 1 | 2010 | 83 | 0.090 |
Why?
| | Hepatitis Delta Virus | 1 | 2009 | 6 | 0.090 |
Why?
| | Fluorouracil | 1 | 2010 | 151 | 0.090 |
Why?
| | Epithelial Cells | 1 | 2015 | 963 | 0.090 |
Why?
| | Adenosine Deaminase | 2 | 2007 | 25 | 0.090 |
Why?
| | Deoxycytidine | 1 | 2010 | 136 | 0.090 |
Why?
| | Cricetulus | 1 | 2009 | 98 | 0.090 |
Why?
| | Positive Transcriptional Elongation Factor B | 2 | 2017 | 22 | 0.090 |
Why?
| | CHO Cells | 1 | 2009 | 143 | 0.090 |
Why?
| | Fibronectins | 3 | 2009 | 114 | 0.090 |
Why?
| | Cricetinae | 1 | 2009 | 262 | 0.090 |
Why?
| | rho GTP-Binding Proteins | 1 | 2009 | 65 | 0.090 |
Why?
| | RNA Transport | 1 | 2008 | 22 | 0.080 |
Why?
| | Active Transport, Cell Nucleus | 1 | 2008 | 113 | 0.080 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2013 | 671 | 0.080 |
Why?
| | Phosphoproteins | 1 | 1990 | 308 | 0.080 |
Why?
| | Ribonucleoproteins | 1 | 2008 | 88 | 0.080 |
Why?
| | Amanitins | 2 | 2004 | 4 | 0.080 |
Why?
| | tat Gene Products, Human Immunodeficiency Virus | 2 | 1998 | 21 | 0.080 |
Why?
| | Bacteroides | 1 | 2007 | 18 | 0.070 |
Why?
| | Mutant Proteins | 1 | 2007 | 100 | 0.070 |
Why?
| | Enzyme Activation | 2 | 2020 | 828 | 0.070 |
Why?
| | Fragile X Mental Retardation Protein | 1 | 2007 | 65 | 0.070 |
Why?
| | Cell Nucleus Structures | 1 | 2006 | 3 | 0.070 |
Why?
| | Heterozygote | 1 | 2007 | 262 | 0.070 |
Why?
| | Oncogenes | 1 | 1986 | 111 | 0.070 |
Why?
| | Receptors, AMPA | 1 | 2007 | 125 | 0.070 |
Why?
| | Allosteric Regulation | 1 | 2006 | 85 | 0.070 |
Why?
| | Fragile X Syndrome | 1 | 2007 | 80 | 0.070 |
Why?
| | Substrate Specificity | 2 | 1997 | 371 | 0.070 |
Why?
| | Uracil | 1 | 2005 | 35 | 0.070 |
Why?
| | Glycoproteins | 1 | 2007 | 319 | 0.060 |
Why?
| | DNA Repair | 2 | 1997 | 198 | 0.060 |
Why?
| | Nucleic Acid Synthesis Inhibitors | 1 | 2004 | 18 | 0.060 |
Why?
| | Physical Chromosome Mapping | 1 | 2004 | 16 | 0.060 |
Why?
| | Chromosomes, Human, Pair 10 | 1 | 2004 | 20 | 0.060 |
Why?
| | Genes, cdc | 1 | 2004 | 10 | 0.060 |
Why?
| | Genetic Testing | 1 | 2007 | 389 | 0.060 |
Why?
| | Sequence Analysis, DNA | 3 | 2004 | 755 | 0.060 |
Why?
| | Oligodeoxyribonucleotides | 2 | 1996 | 139 | 0.060 |
Why?
| | BRCA2 Protein | 1 | 2003 | 44 | 0.060 |
Why?
| | Genome-Wide Association Study | 1 | 2010 | 1323 | 0.060 |
Why?
| | Intestines | 1 | 2007 | 332 | 0.060 |
Why?
| | Colorectal Neoplasms | 1 | 2010 | 628 | 0.060 |
Why?
| | Antineoplastic Agents | 2 | 2013 | 1974 | 0.060 |
Why?
| | RNA, Small Nuclear | 1 | 2003 | 32 | 0.060 |
Why?
| | Amino Acid Motifs | 1 | 2003 | 200 | 0.060 |
Why?
| | Simian virus 40 | 1 | 2002 | 21 | 0.060 |
Why?
| | Nerve Tissue Proteins | 1 | 2007 | 551 | 0.060 |
Why?
| | Tumor Cells, Cultured | 2 | 2017 | 874 | 0.050 |
Why?
| | Binding Sites, Antibody | 1 | 1982 | 38 | 0.050 |
Why?
| | Female | 13 | 2017 | 61565 | 0.050 |
Why?
| | Structure-Activity Relationship | 1 | 2003 | 522 | 0.050 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2010 | 1390 | 0.050 |
Why?
| | NAD(P)H Dehydrogenase (Quinone) | 1 | 2002 | 33 | 0.050 |
Why?
| | Operon | 1 | 1982 | 62 | 0.050 |
Why?
| | Immunoglobulin Variable Region | 1 | 1982 | 71 | 0.050 |
Why?
| | Carcinoma | 1 | 2003 | 204 | 0.050 |
Why?
| | Genomics | 3 | 2013 | 706 | 0.050 |
Why?
| | Ribonucleases | 2 | 2003 | 53 | 0.050 |
Why?
| | Human Genome Project | 1 | 2001 | 16 | 0.050 |
Why?
| | Templates, Genetic | 2 | 1996 | 59 | 0.050 |
Why?
| | HL-60 Cells | 1 | 2020 | 29 | 0.050 |
Why?
| | DNA, Plant | 1 | 1999 | 12 | 0.050 |
Why?
| | Fatigue | 1 | 2002 | 297 | 0.050 |
Why?
| | Chromosomes, Human, Pair 4 | 1 | 1999 | 29 | 0.050 |
Why?
| | Genes, Plant | 1 | 1999 | 44 | 0.050 |
Why?
| | Minichromosome Maintenance Complex Component 2 | 1 | 1999 | 4 | 0.050 |
Why?
| | Cells, Cultured | 2 | 2007 | 4077 | 0.040 |
Why?
| | Holoenzymes | 1 | 1999 | 21 | 0.040 |
Why?
| | RNA Helicases | 1 | 1999 | 20 | 0.040 |
Why?
| | Chromatography, Affinity | 1 | 1999 | 85 | 0.040 |
Why?
| | Lupus Erythematosus, Systemic | 1 | 2002 | 227 | 0.040 |
Why?
| | Arabidopsis | 1 | 1999 | 69 | 0.040 |
Why?
| | Mammals | 2 | 1998 | 253 | 0.040 |
Why?
| | Evolution, Molecular | 3 | 2013 | 454 | 0.040 |
Why?
| | Cell Differentiation | 1 | 1986 | 1753 | 0.040 |
Why?
| | Gene Expression Profiling | 2 | 2017 | 1597 | 0.040 |
Why?
| | Carrier Proteins | 2 | 2003 | 726 | 0.040 |
Why?
| | Enhancer Elements, Genetic | 2 | 2002 | 152 | 0.040 |
Why?
| | Proteins | 3 | 2004 | 938 | 0.040 |
Why?
| | Dogs | 1 | 1999 | 371 | 0.040 |
Why?
| | Peptide Initiation Factors | 1 | 1997 | 17 | 0.040 |
Why?
| | Exercise Therapy | 1 | 2002 | 355 | 0.040 |
Why?
| | Eukaryotic Initiation Factor-4E | 1 | 1997 | 27 | 0.040 |
Why?
| | Tretinoin | 2 | 1990 | 116 | 0.040 |
Why?
| | Mediator Complex | 1 | 1998 | 52 | 0.040 |
Why?
| | Glutathione Transferase | 1 | 1997 | 97 | 0.040 |
Why?
| | Peptide Fragments | 3 | 1998 | 702 | 0.040 |
Why?
| | Nucleic Acid Hybridization | 2 | 1992 | 193 | 0.040 |
Why?
| | Burkitt Lymphoma | 2 | 1988 | 53 | 0.040 |
Why?
| | Alleles | 2 | 2013 | 832 | 0.040 |
Why?
| | Spodoptera | 1 | 1997 | 37 | 0.040 |
Why?
| | Drosophila | 1 | 1998 | 140 | 0.040 |
Why?
| | Cell Survival | 1 | 2020 | 1047 | 0.040 |
Why?
| | Xeroderma Pigmentosum Group D Protein | 1 | 1996 | 4 | 0.040 |
Why?
| | Repetitive Sequences, Nucleic Acid | 2 | 2001 | 103 | 0.040 |
Why?
| | Mice, SCID | 1 | 2017 | 333 | 0.040 |
Why?
| | Sp1 Transcription Factor | 1 | 1996 | 23 | 0.040 |
Why?
| | Lymphatic Metastasis | 1 | 2017 | 307 | 0.040 |
Why?
| | Mutagenesis, Insertional | 1 | 1996 | 61 | 0.040 |
Why?
| | Herpes Simplex Virus Protein Vmw65 | 1 | 1995 | 5 | 0.030 |
Why?
| | 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine | 1 | 1995 | 29 | 0.030 |
Why?
| | Cloning, Molecular | 2 | 1990 | 546 | 0.030 |
Why?
| | Mice, Inbred NOD | 1 | 2017 | 574 | 0.030 |
Why?
| | Rabbits | 1 | 1997 | 780 | 0.030 |
Why?
| | Simplexvirus | 1 | 1995 | 86 | 0.030 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2017 | 740 | 0.030 |
Why?
| | Oligonucleotide Probes | 1 | 1994 | 53 | 0.030 |
Why?
| | Estrogens | 1 | 2017 | 328 | 0.030 |
Why?
| | TATA Box | 1 | 1994 | 24 | 0.030 |
Why?
| | Apoptosis | 2 | 2017 | 2484 | 0.030 |
Why?
| | Histone Deacetylase 1 | 1 | 2014 | 16 | 0.030 |
Why?
| | Blotting, Western | 1 | 1997 | 1194 | 0.030 |
Why?
| | Granulosa Cell Tumor | 1 | 2013 | 6 | 0.030 |
Why?
| | Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2014 | 24 | 0.030 |
Why?
| | Time-Lapse Imaging | 1 | 2013 | 19 | 0.030 |
Why?
| | Minor Histocompatibility Antigens | 1 | 2013 | 41 | 0.030 |
Why?
| | Mediator Complex Subunit 1 | 1 | 2013 | 4 | 0.030 |
Why?
| | Retinoblastoma Protein | 1 | 2013 | 52 | 0.030 |
Why?
| | Piperazines | 1 | 1995 | 316 | 0.030 |
Why?
| | Hyperplasia | 1 | 2013 | 170 | 0.030 |
Why?
| | Molecular Weight | 2 | 1990 | 343 | 0.030 |
Why?
| | Multimodal Imaging | 1 | 2013 | 100 | 0.030 |
Why?
| | HIV | 1 | 1994 | 210 | 0.030 |
Why?
| | Class I Phosphatidylinositol 3-Kinases | 1 | 2013 | 80 | 0.030 |
Why?
| | Genetics, Medical | 2 | 2004 | 26 | 0.030 |
Why?
| | Tomography, Optical Coherence | 1 | 2013 | 126 | 0.030 |
Why?
| | Gene Duplication | 2 | 2004 | 64 | 0.030 |
Why?
| | Gene Knockdown Techniques | 1 | 2013 | 311 | 0.030 |
Why?
| | Ubiquitination | 1 | 2012 | 87 | 0.030 |
Why?
| | CpG Islands | 2 | 2004 | 119 | 0.030 |
Why?
| | Immunoblotting | 1 | 2012 | 307 | 0.030 |
Why?
| | DNA Mutational Analysis | 1 | 2013 | 381 | 0.030 |
Why?
| | Exome | 1 | 2013 | 220 | 0.030 |
Why?
| | Plant Proteins | 2 | 2003 | 81 | 0.030 |
Why?
| | Cytochrome b Group | 1 | 1991 | 15 | 0.030 |
Why?
| | Dinucleoside Phosphates | 1 | 1991 | 22 | 0.020 |
Why?
| | X Chromosome | 1 | 1991 | 47 | 0.020 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2013 | 369 | 0.020 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2013 | 341 | 0.020 |
Why?
| | Genes, Recessive | 1 | 1991 | 73 | 0.020 |
Why?
| | Biomarkers, Tumor | 1 | 2017 | 1059 | 0.020 |
Why?
| | Organoplatinum Compounds | 1 | 2010 | 41 | 0.020 |
Why?
| | Intracellular Membranes | 1 | 1990 | 74 | 0.020 |
Why?
| | Capecitabine | 1 | 2010 | 46 | 0.020 |
Why?
| | Up-Regulation | 1 | 2013 | 872 | 0.020 |
Why?
| | NADPH Oxidases | 1 | 1990 | 138 | 0.020 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 2 | 2013 | 968 | 0.020 |
Why?
| | Point Mutation | 2 | 2003 | 228 | 0.020 |
Why?
| | Cell Proliferation | 1 | 2017 | 2275 | 0.020 |
Why?
| | Protein Kinase Inhibitors | 1 | 1995 | 811 | 0.020 |
Why?
| | ErbB Receptors | 1 | 2013 | 569 | 0.020 |
Why?
| | Fluorescence Recovery After Photobleaching | 1 | 2009 | 18 | 0.020 |
Why?
| | Binding, Competitive | 1 | 1989 | 205 | 0.020 |
Why?
| | Kidney | 1 | 1996 | 1353 | 0.020 |
Why?
| | DNA Restriction Enzymes | 1 | 1988 | 53 | 0.020 |
Why?
| | Neoplasm Metastasis | 1 | 2010 | 544 | 0.020 |
Why?
| | Peptide Chain Initiation, Translational | 1 | 1988 | 38 | 0.020 |
Why?
| | Protein Biosynthesis | 2 | 1988 | 397 | 0.020 |
Why?
| | Translocation, Genetic | 1 | 1987 | 92 | 0.020 |
Why?
| | Trinucleotide Repeat Expansion | 1 | 2007 | 26 | 0.020 |
Why?
| | Nucleic Acid Amplification Techniques | 1 | 2007 | 38 | 0.020 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2009 | 770 | 0.020 |
Why?
| | DNA Damage | 1 | 2009 | 357 | 0.020 |
Why?
| | Deoxyribonucleases | 1 | 1986 | 21 | 0.020 |
Why?
| | Symbiosis | 1 | 2007 | 63 | 0.020 |
Why?
| | Antibodies, Phospho-Specific | 1 | 2006 | 1 | 0.020 |
Why?
| | Lung Neoplasms | 2 | 2013 | 2220 | 0.020 |
Why?
| | Gene Deletion | 1 | 2007 | 361 | 0.020 |
Why?
| | Lymphoma | 1 | 1986 | 180 | 0.020 |
Why?
| | Adult | 3 | 2017 | 31512 | 0.020 |
Why?
| | Neutrophils | 1 | 1990 | 1233 | 0.020 |
Why?
| | Contig Mapping | 1 | 2004 | 10 | 0.020 |
Why?
| | Pseudogenes | 1 | 2004 | 20 | 0.020 |
Why?
| | Base Composition | 1 | 2004 | 77 | 0.020 |
Why?
| | Pan troglodytes | 1 | 2004 | 57 | 0.020 |
Why?
| | Leukocytes, Mononuclear | 1 | 2007 | 509 | 0.020 |
Why?
| | Co-Repressor Proteins | 1 | 2003 | 17 | 0.010 |
Why?
| | Adenovirus E1A Proteins | 1 | 2003 | 11 | 0.010 |
Why?
| | Chromosomes, Human, Pair 11 | 1 | 2003 | 66 | 0.010 |
Why?
| | Gene Amplification | 1 | 2003 | 97 | 0.010 |
Why?
| | DNA, Complementary | 1 | 2003 | 268 | 0.010 |
Why?
| | Gene Silencing | 1 | 2003 | 177 | 0.010 |
Why?
| | Antigens, Polyomavirus Transforming | 1 | 2002 | 14 | 0.010 |
Why?
| | Replication Origin | 1 | 2002 | 15 | 0.010 |
Why?
| | Adenoviridae | 1 | 2003 | 191 | 0.010 |
Why?
| | Nucleic Acid Conformation | 1 | 2006 | 670 | 0.010 |
Why?
| | Microscopy, Immunoelectron | 1 | 2002 | 45 | 0.010 |
Why?
| | HT29 Cells | 1 | 2002 | 37 | 0.010 |
Why?
| | COS Cells | 1 | 2002 | 184 | 0.010 |
Why?
| | Immunoglobulin Light Chains | 1 | 1982 | 35 | 0.010 |
Why?
| | Protein Isoforms | 1 | 2003 | 345 | 0.010 |
Why?
| | Gene Expression Regulation, Viral | 1 | 2002 | 84 | 0.010 |
Why?
| | Ecosystem | 1 | 2007 | 555 | 0.010 |
Why?
| | Drosophila melanogaster | 1 | 2003 | 200 | 0.010 |
Why?
| | Bacteriophage lambda | 1 | 1982 | 81 | 0.010 |
Why?
| | GC Rich Sequence | 1 | 2001 | 4 | 0.010 |
Why?
| | B-Lymphocytes | 1 | 1986 | 770 | 0.010 |
Why?
| | Public Sector | 1 | 2001 | 18 | 0.010 |
Why?
| | Bacterial Proteins | 1 | 2007 | 759 | 0.010 |
Why?
| | Private Sector | 1 | 2001 | 51 | 0.010 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 982 | 0.010 |
Why?
| | Microscopy, Confocal | 1 | 2002 | 314 | 0.010 |
Why?
| | Genetic Diseases, Inborn | 1 | 2001 | 46 | 0.010 |
Why?
| | Physical Fitness | 1 | 2002 | 179 | 0.010 |
Why?
| | DNA Transposable Elements | 1 | 2001 | 102 | 0.010 |
Why?
| | Conserved Sequence | 1 | 2001 | 219 | 0.010 |
Why?
| | Respiratory Function Tests | 1 | 2002 | 526 | 0.010 |
Why?
| | Disability Evaluation | 1 | 2002 | 280 | 0.010 |
Why?
| | Phylogeny | 1 | 2003 | 816 | 0.010 |
Why?
| | Leukemia, Myeloid, Acute | 1 | 1986 | 532 | 0.010 |
Why?
| | Drug Industry | 1 | 2001 | 104 | 0.010 |
Why?
| | Chromosome Mapping | 1 | 2001 | 510 | 0.010 |
Why?
| | Homeodomain Proteins | 1 | 2003 | 468 | 0.010 |
Why?
| | Heterochromatin | 1 | 1999 | 38 | 0.010 |
Why?
| | Species Specificity | 1 | 2001 | 565 | 0.010 |
Why?
| | Chromosomes | 1 | 1999 | 87 | 0.010 |
Why?
| | Quality of Life | 1 | 2010 | 2366 | 0.010 |
Why?
| | Regression Analysis | 1 | 2002 | 983 | 0.010 |
Why?
| | Oxygen Consumption | 1 | 2002 | 586 | 0.010 |
Why?
| | Exercise Test | 1 | 2002 | 551 | 0.010 |
Why?
| | Sequence Homology, Amino Acid | 1 | 1999 | 372 | 0.010 |
Why?
| | Forecasting | 1 | 2001 | 353 | 0.010 |
Why?
| | Multigene Family | 1 | 1999 | 200 | 0.010 |
Why?
| | Genetic Variation | 1 | 2004 | 926 | 0.010 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2003 | 1945 | 0.010 |
Why?
| | Cloning, Organism | 1 | 1998 | 6 | 0.010 |
Why?
| | Protein Sorting Signals | 1 | 1998 | 15 | 0.010 |
Why?
| | Genetic Complementation Test | 1 | 1998 | 62 | 0.010 |
Why?
| | Cations, Divalent | 1 | 1998 | 52 | 0.010 |
Why?
| | Guanosine Triphosphate | 1 | 1998 | 87 | 0.010 |
Why?
| | Heart Rate | 1 | 2002 | 729 | 0.010 |
Why?
| | Fetus | 1 | 1982 | 690 | 0.010 |
Why?
| | Proteome | 1 | 2001 | 353 | 0.010 |
Why?
| | Mutagenesis, Site-Directed | 1 | 1998 | 363 | 0.010 |
Why?
| | Rats | 1 | 2006 | 5392 | 0.010 |
Why?
| | Protein Conformation | 1 | 1999 | 848 | 0.010 |
Why?
| | Databases, Factual | 1 | 2001 | 1231 | 0.010 |
Why?
| | Prognosis | 1 | 2003 | 3443 | 0.010 |
Why?
| | Genetic Predisposition to Disease | 1 | 2003 | 2275 | 0.010 |
Why?
| | Liver | 1 | 1982 | 1816 | 0.010 |
Why?
| | Aged | 1 | 2010 | 19657 | 0.010 |
Why?
| | Restriction Mapping | 1 | 1991 | 76 | 0.010 |
Why?
| | Exercise | 1 | 2002 | 1657 | 0.010 |
Why?
| | Prospective Studies | 1 | 2002 | 6471 | 0.010 |
Why?
| | Middle Aged | 1 | 2010 | 27617 | 0.010 |
Why?
| | Pregnancy | 1 | 1982 | 5691 | 0.010 |
Why?
| | Reference Values | 1 | 1991 | 774 | 0.010 |
Why?
| | DNA, Recombinant | 1 | 1988 | 42 | 0.010 |
Why?
| | Chromosomes, Human, Pair 14 | 1 | 1987 | 17 | 0.000 |
Why?
| | Chromosomes, Human, Pair 2 | 1 | 1987 | 28 | 0.000 |
Why?
| | Chromosomes, Human, Pair 8 | 1 | 1987 | 32 | 0.000 |
Why?
| | Chromosomes, Human, Pair 22 | 1 | 1987 | 39 | 0.000 |
Why?
| | Codon | 1 | 1988 | 89 | 0.000 |
Why?
| | Chickens | 1 | 1988 | 185 | 0.000 |
Why?
| | Male | 1 | 2010 | 57801 | 0.000 |
Why?
| | Biological Evolution | 1 | 1988 | 443 | 0.000 |
Why?
|
|
Bentley's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|